Vulnerabilities

Vulnerability · CVE-2015-20114

RealtyScript 4.0.2 Cross-Site Scripting via Multiple Parameters

Published Mar 15, 2026 · catalog updated Jun 17, 2026 · Next Click Ventuers RealtyScript

Check if you run it

No confirmed exploitation is on record for CVE-2015-20114. EPSS is 0.29%. Act only if a listed version of Next Click Ventuers RealtyScript is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.29%
Remediation
Advisory link
Affected products
cpe nextclickventures/realtyscript · vendor Next Click Ventuers RealtyScript

Next Click Ventures RealtyScript 4.0.2 contains a cross-site scripting vulnerability that allows attackers to execute arbitrary HTML and script code by injecting malicious input through multiple parameters that are not properly sanitized. Attackers can craft requests with injected script payloads in vulnerable parameters to execute code in users' browser sessions within the context of the affected application.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe nextclickventures/realtyscript4.0.2
  • vendor Next Click Ventuers RealtyScriptversion unspecified

How to fix CVE-2015-20114

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2015-20114. EPSS is 0.29%. Act only if a listed version of Next Click Ventuers RealtyScript is installed.

Which versions are affected?

Compare what you have installed with 4.0.2. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.29%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 16, 2026 · NIST NVD

    Detected

    Next Click Ventures RealtyScript 4.0.2 contains a cross-site scripting vulnerability that allows attackers to execute arbitrary HTML and script code by injecting malicious input through multiple parameters that are not properly sanitized. Attackers can craft requests with injected script payloads in vulnerable parameters to execute code in users' browser sessions within the context of the affected

  2. Jun 17, 2026 · NIST NVD

    Updated

    Next Click Ventures RealtyScript 4.0.2 contains a cross-site scripting vulnerability that allows attackers to execute arbitrary HTML and script code by injecting malicious input through multiple parameters that are not properly sanitized. Attackers can craft requests with injected script payloads in vulnerable parameters to execute code in users' browser sessions within the context of the affected

Sources

  • CVE.orgVulnerability recordCVE-2015-20114

    Next Click Ventures RealtyScript 4.0.2 contains a cross-site scripting vulnerability that allows attackers to execute arbitrary HTML and script code by injecting malicious input through multiple parameters that are not properly sanitized. Attackers can craft requests with injecte

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2015-20114

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2015-20114

    Next Click Ventures RealtyScript 4.0.2 contains a cross-site scripting vulnerability that allows attackers to execute arbitrary HTML and script code by injecting malicious input through multiple parameters that are not properly sanitized. Attackers can craft requests with injecte

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.